Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

26.29

-0.22 (-0.83%)

At close: Feb 26, 2026, 4:00 PM EST

26.21

-0.08 (-0.30%)

After-hours: Feb 26, 2026, 7:55 PM EST

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	13,000	8,426	44	300	450	-
Market Cap Growth	26647.65%	19171.44%	-85.42%	-33.42%	-	-
Enterprise Value	12,996	8,418	39	284	452	-
Last Close Price	26.29	17.04	0.09	0.61	0.91	-
PB Ratio	2674.77	1733.67	5.32	25.01	26.36	-
P/TBV Ratio	2674.77	1733.67	5.32	24.92	26.39	-
Debt / Equity Ratio	0.11	0.11	0.01	0.04	0.05	-0.92
Net Debt / Equity Ratio	-0.90	-0.90	-0.96	-0.93	-0.92	-0.91
Net Debt / EBITDA Ratio	1.18	1.18	1.78	1.86	2.10	-2.67
Net Debt / FCF Ratio	1.33	1.33	1.97	2.23	2.59	-4.72
Quick Ratio	7.38	7.38	41.13	19.06	28.42	0.01
Current Ratio	7.39	7.39	41.92	19.15	28.46	0.02
Return on Equity (ROE)	-54.81%	-54.81%	-43.18%	-41.71%	-116.10%	-
Return on Assets (ROA)	-33.20%	-33.20%	-28.11%	-25.59%	-51.87%	-202.15%
Return on Capital Employed (ROCE)	-74.00%	-74.00%	-57.50%	-52.20%	-43.70%	34.60%
Earnings Yield	-0.03%	-0.04%	-9.84%	-1.96%	-1.65%	-
FCF Yield	-0.03%	-0.04%	-9.16%	-1.66%	-1.34%	-
Buyback Yield / Dilution	-	-	-	-1.62%	-28.06%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q